Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v25-FR | Version v3-EN | |
---|---|---|
Language | French | English |
Date Updated | 2023-05-30 | 2022-10-25 |
Drug Identification Number | 02242529 | 02242529 |
Brand name | MULTI-12/K1 PEDIATRIC | MULTI-12/K1 PEDIATRIC |
Common or Proper name | MULTI-12/K1 PED | MULTI-12/K1 PED |
Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
Ingredients | VITAMIN D VITAMIN A ASCORBIC ACID VITAMIN B12 FOLIC ACID BIOTIN VITAMIN K1 VITAMIN E DEXPANTHENOL NICOTINAMIDE PYRIDOXINE HYDROCHLORIDE VITAMIN B2 VITAMIN B1 | VITAMIN D VITAMIN A ASCORBIC ACID VITAMIN B12 FOLIC ACID BIOTIN VITAMIN K1 VITAMIN E DEXPANTHENOL NICOTINAMIDE PYRIDOXINE HYDROCHLORIDE VITAMIN B2 VITAMIN B1 |
Strength(s) | 400UNIT 2300UNIT 80MG 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG | 400UNIT 2300UNIT 80MG 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG |
Dosage form(s) | LIQUID | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | SINGLE DOSE 10LIVI | SINGLE DOSE 10LIVI |
ATC code | B05XC | B05XC |
ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2022-11-28 | 2022-10-25 |
Estimated end date | 2023-05-26 | 2022-11-18 |
Actual end date | 2023-05-19 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Baxter item : 6461 | Baxter item : 6461 Product is available on allocation based on 85% of historical volumes |
Health Canada comments |